27570548|t|PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.
27570548|a|In vivo Positron Emission Tomography (PET) imaging of the cystine-glutamate antiporter (system xc(-)) activity with [(18)F]FSPG is meant to be an attractive tool for the diagnosis and therapy evaluation of brain diseases. However, the role of system xc(-) in cerebral ischemia and its involvement in inflammatory reaction has been scarcely explored. In this work, we report the longitudinal investigation of the neuroinflammatory process following transient middle cerebral artery occlusion (MCAO) in rats using PET with [(18)F]FSPG and the translocator protein (TSPO) ligand [(18)F]DPA-714. In the ischemic territory, [(18)F]FSPG showed a progressive binding increase that peaked at days 3 to 7 and was followed by a progressive decrease from days 14 to 28 after reperfusion. In contrast, [(18)F]DPA-714 evidenced maximum binding uptake values over day 7 after reperfusion. Ex vivo immnunohistochemistry confirmed the up-regulation of system xc(-) in microglial cells and marginally in astrocytes. Inhibition of system xc(-) with sulfasalazine and S-4-CPG resulted in increased arginase (anti-inflammatory M2 marker) expression at day 7 after ischemia, together with a decrease in TSPO and microglial M1 proinflammatory markers (CCL2, TNF and iNOS) expression. Taken together, these results suggest that system xc(-) plays a key role in the inflammatory reaction underlying experimental stroke.
27570548	17	28	[(18)F]FSPG	Chemical	MESH:C000623325
27570548	58	61	xc(	Chemical	-
27570548	67	85	Brain Inflammation	Disease	MESH:D004660
27570548	96	113	Cerebral Ischemia	Disease	MESH:D002545
27570548	117	121	Rats	Species	10116
27570548	218	221	xc(	Chemical	-
27570548	239	250	[(18)F]FSPG	Chemical	MESH:C000623325
27570548	329	343	brain diseases	Disease	MESH:D001927
27570548	373	376	xc(	Chemical	-
27570548	382	399	cerebral ischemia	Disease	MESH:D002545
27570548	423	435	inflammatory	Disease	MESH:D007249
27570548	535	552	neuroinflammatory	Disease	MESH:D000090862
27570548	581	613	middle cerebral artery occlusion	Disease	MESH:D020244
27570548	615	619	MCAO	Disease	MESH:D020244
27570548	624	628	rats	Species	10116
27570548	644	655	[(18)F]FSPG	Chemical	MESH:C000623325
27570548	664	684	translocator protein	Gene	24230
27570548	686	690	TSPO	Gene	24230
27570548	699	713	[(18)F]DPA-714	Chemical	-
27570548	722	730	ischemic	Disease	MESH:D002545
27570548	742	753	[(18)F]FSPG	Chemical	MESH:C000623325
27570548	913	927	[(18)F]DPA-714	Chemical	-
27570548	1066	1069	xc(	Chemical	-
27570548	1143	1146	xc(	Chemical	-
27570548	1154	1167	sulfasalazine	Chemical	MESH:D012460
27570548	1172	1179	S-4-CPG	Chemical	MESH:C079693
27570548	1217	1229	inflammatory	Disease	MESH:D007249
27570548	1267	1275	ischemia	Disease	MESH:D007511
27570548	1305	1309	TSPO	Gene	24230
27570548	1328	1343	proinflammatory	Disease	
27570548	1353	1357	CCL2	Gene	24770
27570548	1359	1362	TNF	Gene	24835
27570548	1367	1371	iNOS	Gene	24599
27570548	1435	1438	xc(	Chemical	-
27570548	1465	1477	inflammatory	Disease	MESH:D007249
27570548	1511	1517	stroke	Disease	MESH:D020521
27570548	Association	MESH:C000623325	MESH:D004660
27570548	Negative_Correlation	MESH:D012460	MESH:D007249
27570548	Negative_Correlation	MESH:C079693	MESH:D007249
27570548	Negative_Correlation	MESH:D012460	24770
27570548	Negative_Correlation	MESH:C079693	24835
27570548	Negative_Correlation	MESH:C079693	24770
27570548	Negative_Correlation	MESH:C079693	24599
27570548	Association	MESH:C000623325	MESH:D001927
27570548	Negative_Correlation	MESH:D012460	MESH:D007511
27570548	Negative_Correlation	MESH:D012460	24835
27570548	Association	MESH:C000623325	MESH:D002545
27570548	Negative_Correlation	MESH:D012460	24599
27570548	Negative_Correlation	MESH:D012460	24230
27570548	Negative_Correlation	MESH:C079693	MESH:D007511
27570548	Negative_Correlation	MESH:C079693	24230

